🔗 Share this article

The prestigious award in medical science was granted for transformative findings that illuminate how the immune system attacks dangerous pathogens while sparing the body's own cells.

Three renowned researchers—Japan's Shimon Sakaguchi and American experts Mary Brunkow and Dr. Ramsdell—share this accolade.

The work identified specialized "sentinels" within the defense system that eliminate malfunctioning immune cells capable of harming the organism.

The discoveries are now enabling new treatments for immune disorders and malignancies.

These winners will share a monetary award valued at 11 million SEK.

Crucial Discoveries

"The research has been decisive for comprehending how the immune system operates and the reason we don't all suffer from serious self-attack conditions," stated the head of the award panel.

This trio's research address a core mystery: In what way does the defense system protect us from countless infections while keeping our own tissues unharmed?

Our immune system uses white blood cells that scan for signs of infection, even viruses and bacteria it has not met before.

Such defenders employ sensors—called receptors—that are generated randomly in a vast number of variations.

This gives the immune system the ability to combat a broad range of invaders, but the unpredictability of the mechanism inevitably creates white blood cells that may attack the body.

Protectors of the Immune System

Researchers previously understood that some of these harmful white blood cells were destroyed in the thymus—where white blood cells mature.

This year's Nobel Prize honors the discovery of regulatory T-cells—known as the immune system's "peacekeepers"—which travel through the body to disarm any immune cells that attack the healthy cells.

We know that this mechanism fails in self-attack conditions such as type-1 diabetes, MS, and RA.

The prize committee stated, "The discoveries have established a novel area of research and accelerated the creation of innovative therapies, for example for tumors and autoimmune diseases."

In cancer, T-regs prevent the system from attacking the tumor, so research are focused on reducing their numbers.

In autoimmune diseases, trials are testing increasing regulatory T-cells so the organism is no longer under attack. A similar approach could also be useful in reducing the risks of organ transplant rejection.

Innovative Studies

Prof Shimon Sakaguchi, from a Japanese institution, performed tests on mice that had their thymus extracted, leading to self-attack conditions.

The researcher demonstrated that injecting defense cells from healthy mice could stop the illness—suggesting there was a mechanism for blocking defenders from harming the body.

Mary Brunkow, from the Institute for Systems Biology in Seattle, and Dr. Ramsdell, now at Sonoma Biotherapeutics in San Francisco, were studying an inherited immune disorder in rodents and people that resulted in the identification of a gene vital for the way T-regs function.

"The groundbreaking research has revealed how the immune system is controlled by T-reg cells, preventing it from accidentally attacking the body's own tissues," said a prominent biological science specialist.

"This work is a remarkable illustration of how basic biological study can have far-reaching consequences for human health."